Biotechnology News

Vancouver, British Columbia--(Newsfile Corp. - December 1, 2020) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced it has entered into a Clinical Study Agreement with the Contract Research Organization (CRO) Centre for Human...
Biotechnology, Pharmaceuticals, Cannabis
2020-12-01 8:30 AM ET | Entheon Biomedical Corp.

100% control of Fusarium wilt TR4.National State of Emergency declared in Colombia in 2019.Fusarium wilt TR4 is existential threat to the $25 billion global banana industry.Saskatoon, Saskatchewan--(Newsfile Corp. - December 1, 2020) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announ
Agriculture, Biotechnology, Cannabis, Health
2020-12-01 7:02 AM ET | MustGrow Biologics Corp.

Ottawa, Ontario--(Newsfile Corp. - November 30, 2020) -  Enablence Technologies Inc. (TSXV: ENA) ("Enablence" or the "Company"), a leading supplier of optical components and subsystems, today announces that its interim financial statements and accompanying management discussion and analysis for the three months ended September 30, 2020 (the "Quarterly Financial Information")...
Technology, Biotechnology, Telecommunications
2020-11-30 5:43 PM ET | Enablence Technologies Inc.

Toronto, Ontario--(Newsfile Corp. - November 30, 2020) -  American Aires Inc. (CSE: WIFI) (the "Company" or "Aires") is pleased to announce the financial results for the three months ended September 30, 2020. All financial information is provided in Canadian dollars unless otherwise indicated.Key Third Quarter Highlights:Total revenue for the three...
Technology, Biotechnology
2020-11-30 8:30 AM ET | American Aires Inc.

Vancouver, British Columbia--(Newsfile Corp. - November 30, 2020) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) ("BioVaxys" or "the Company") is pleased to announce that it has received further data from its successfully completed murine model study demonstrating that immunizing mice with two doses of BVX-0320, its COVID-19 vaccine...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2020-11-30 8:00 AM ET | BioVaxys Technology Corp.

Vancouver, British Columbia--(Newsfile Corp. - November 26, 2020) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) ("Nextleaf Solutions", "OILS", or the "Company"), Canada's most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:Cannabis Extraction Agreement with White Label ProducerThe Company's wholly owned subsidiary Nextleaf...
Biotechnology, Pharmaceuticals, Cannabis, Health
2020-11-26 9:00 AM ET | Nextleaf Solutions Ltd.

Vancouver, British Columbia--(Newsfile Corp. - November 26, 2020) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce that its shares have commenced trading on the Frankfurt...
Biotechnology, Pharmaceuticals, Cannabis
2020-11-26 8:30 AM ET | Entheon Biomedical Corp.

Toronto, Ontario--(Newsfile Corp. - November 25, 2020) - Media Central Corporation Inc. ("Media Central" or the "Corporation") announced today the cancellation of the special meeting of shareholders of the Corporation (the "Meeting"), scheduled for December 30, 2020.Cancellation of the MeetingThe Meeting was announced further to a requisition (the "Requisition")...
Biotechnology, Publishing/Informational Services
2020-11-25 7:03 PM ET | Media Central Corporation Inc.

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to announce the successful laboratory development of a cannabinoid Sol-Gel formulation ("SARS-CoV-2 Sol-Gel") as a potential prevention/treatment for COVID-19 caused by SARS-CoV-2 infection.Independent scientific literature has reported that high CBD strains...
Biotechnology, Pharmaceuticals, Health
2020-11-25 8:00 AM ET | PreveCeutical Medical Inc.

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - November 24, 2020) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") today announced it will intensify its near-term direction to accelerate revenue growth in 2021 and focus on sales and marketing in key regions for...
Technology, Agriculture, Biotechnology
2020-11-24 8:00 AM ET | Bee Vectoring Technologies International Inc.

Saskatoon, Saskatchewan--(Newsfile Corp. - November 24, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness...
Agriculture, Biotechnology, Cannabis, Health
2020-11-24 7:02 AM ET | MustGrow Biologics Corp.

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - November 24, 2020) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") today announced it will intensify its near-term direction to accelerate revenue growth in 2021 and focus on sales and marketing in key regions...
Technology, Agriculture, Biotechnology
2020-11-24 1:00 AM ET | Bee Vectoring Technologies International Inc.

Toronto, Ontario--(Newsfile Corp. - November 23, 2020) - American Aires Inc. (CSE: WIFI) (the "Company" or "Aires"), a world leader in developing and bringing electromagnetic radiation protection (EMR) products to market, today announced the launch of "LIFETUNE", a revolutionary new line of EMR protection offerings that are optimized for...
Technology, Biotechnology
2020-11-23 9:38 AM ET | American Aires Inc.

Vancouver, British Columbia--(Newsfile Corp. - November 23, 2020) -  PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has filed a provisional application at the Australian Patent Office on November 20, 2020, entitled "Sol-Gel Cannabinoid Formulation and Antiviral Use", application number 20200904291, with...
Biotechnology, Pharmaceuticals, Health
2020-11-23 7:30 AM ET | PreveCeutical Medical Inc.

Exclusive patent licensed from University of Idaho.Mustard-derived fumigation of stored food - targeting vegetables and potatoes.Leading agrochemical for sprout suppression - chlorpropham - banned by European Union on Oct. 8, 2020.Appointment of Scientific Advisor Dr. Matthew J. Morra, professor emeritus of soil biochemistry at University of Ida
Agriculture, Biotechnology, Cannabis, Health
2020-11-23 7:02 AM ET | MustGrow Biologics Corp.

Toronto, Ontario--(Newsfile Corp. - November 19, 2020) - Media Central Corporation Inc. ("Media Central" or the "Corporation") announced today: (i) the appointment to the Corporation's Board of Directors (the "Board") of three new directors, (ii) the resignation of the four incumbent directors and (iii) the resignation of Media Central's...
Biotechnology, Publishing/Informational Services
2020-11-19 5:11 PM ET | Media Central Corporation Inc.

Ottawa, Ontario--(Newsfile Corp. - November 16, 2020) - Enablence Technologies Inc. (TSXV: ENA) ("Enablence" or the "Company"), a leading supplier of optical components and subsystems for access, metro and long-haul markets, today announced that Mr. Yongxing Zhu has resigned as a director of the Company effective immediately. The Board...
Technology, Biotechnology, Telecommunications
2020-11-16 5:44 PM ET | Enablence Technologies Inc.

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2020) - Naturally Splendid Enterprises Ltd. (FSE: 50N) (TSXV: NSP) (OTCQB: NSPDF) ("Naturally Splendid", "NSE" or "the Company") is pleased to announce the appointment of Mr. Kris Tarr to the Advisory Board, assisting in the area of e-commerce and online marketing.Mr. Tarr's...
Biotechnology, Cannabis, Health
2020-11-13 8:48 AM ET | Naturally Splendid Enterprises Ltd.

La Jolla, California--(Newsfile Corp. - November 12, 2020) - Tryp Therapeutics, a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today it has appointed Dr. Jim Gilligan as President and Chief Scientific Officer.Dr. Gilligan brings over 30 years of drug development...
Biotechnology, Pharmaceuticals
2020-11-12 12:26 PM ET | TRYP Therapeutics